This overview highlights emerging treatments for neovascular AMD, including new tyrosine kinase inhibitors and promising gene therapy programs. Clinical trials over the next two years may bring long-term, more durable treatment options for patients.
CardiologyIMMUNOLOGYOphthalmology < class="penci-entry-title entry-title grid-title penci_grid_title">New technologies advance wet AMD treatment space